Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Why Is NIO Stock Up 10% Today?

By Dana Blankenhorn, InvestorPlace Contributor

Chinese investors rushed back into local exchanges, sending Chinese stocks traded in New York like Nio higher.

5 Chinese Stocks Worth Buying on the President Xi Freefall

By Dana Blankenhorn, InvestorPlace Contributor

Chinese stocks traded in New York still suffer from a Xi Jinping hangover, but are down no more than their U.S. counterparts.

Carl Icahn Is Making a Big Bet on Crown (CCK) Stock. Here’s Why.

By Dana Blankenhorn, InvestorPlace Contributor

Crown Holdings is like to accede to Icahn's demand that it dumps its growth acquisition and hand him the money.

LAC Stock Alert: Lithium Americas Plans to Split Up

By Dana Blankenhorn, InvestorPlace Contributor

Lithium is a hot commodity, but Argentine inflation has raised Lithium Americas' costs to get a nearly-completed mine into production.

Why Is Abiomed (ABMD) Stock Up 50% Today?

By Dana Blankenhorn, InvestorPlace Contributor

Abiomed will become part of Johnson & Johnson's huge medical devices unit after being bought for $16.6 billion in cash.

SOFI Stock Gains After Boosting Full-Year Forecast

By Dana Blankenhorn, InvestorPlace Contributor

SoFi still lacks a net profit, but when income taxes, amortization and depreciation are taken out it's running well.

Why Is Emerson (EMR) Stock Up Today?

By Dana Blankenhorn, InvestorPlace Contributor

Emerson secured a $2.25 billion loan in the deal, bypassing commercial banks as it moves to increase its industrial business.

Petrobras (PBR) Stock Falls 8% on Lula Victory in Brazil

By Dana Blankenhorn, InvestorPlace Contributor

Bolsonaro has yet to concede defeat, adding uncertainty to all Brazilian stocks -- especially state-run oil company PBR stock.

What Is Going on With Selina Hospitality (SLNA) Stock?

By Dana Blankenhorn, InvestorPlace Contributor

Selina says it already has over 35,000 beds focused on Generation Z travelers who may use it for vacations and co-working space.

How AMC Stock Could Fall 85% From Here

By Dana Blankenhorn, InvestorPlace Contributor

There are still some on WallStreetBets who believe in AMC and in Gamestop, but both stocks have fallen steadily in 2022.

Load More